enGene Therapeutics Inc. (ENGN) income statement
ENGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends October 31Also trades as ENGNW
$1.74−0.02 (-1.14%)
Close on Nov 20, 2026Market cap $116.61MP/E –Yield 0.00%
enGene Therapeutics Inc. financial ratios
See a number that looks wrong?